← 產業報告目錄
Anti-TNF-α Monoclonal Antibody Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 112報告編號 APO-ff9ae4cd59
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Anti-TNF-α Monoclonal Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anti-TNF-α Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anti-TNF-α Monoclonal Antibody is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Anti-TNF-α Monoclonal Antibody is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anti-TNF-α Monoclonal Antibody include Abbive, Johnson and Johnson and UCB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anti-TNF-α Monoclonal Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-TNF-α Monoclonal Antibody Market by Company
Abbive
Johnson and Johnson
UCB
Anti-TNF-α Monoclonal Antibody Segment by Type
Infliximab
Pecerizumab
Golimumab
Adalimumab
Anti-TNF-α Monoclonal Antibody Segment by Application
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriasis
Other
Anti-TNF-α Monoclonal Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-TNF-α Monoclonal Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-TNF-α Monoclonal Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-TNF-α Monoclonal Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-TNF-α Monoclonal Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-TNF-α Monoclonal Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-TNF-α Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Anti-TNF-α Monoclonal Antibody Market Size (2021-2032)
2.2.2 Global Anti-TNF-α Monoclonal Antibody Sales (2021-2032)
2.2.3 Global Anti-TNF-α Monoclonal Antibody Market Average Price (2021-2032)
2.3 Anti-TNF-α Monoclonal Antibody by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Infliximab
2.3.3 Pecerizumab
2.3.4 Golimumab
2.3.5 Adalimumab
2.4 Anti-TNF-α Monoclonal Antibody by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Rheumatoid Arthritis
2.4.3 Ankylosing Spondylitis
2.4.4 Psoriasis
2.4.5 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Anti-TNF-α Monoclonal Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Anti-TNF-α Monoclonal Antibody Sales (Kg) of Manufacturers (2021-2026)
3.3 Global Anti-TNF-α Monoclonal Antibody Revenue of Manufacturers (2021-2026)
3.4 Global Anti-TNF-α Monoclonal Antibody Average Price by Manufacturers (2021-2026)
3.5 Global Anti-TNF-α Monoclonal Antibody Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Anti-TNF-α Monoclonal Antibody, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Anti-TNF-α Monoclonal Antibody, Product Type & Application
3.8 Global Manufacturers of Anti-TNF-α Monoclonal Antibody, Established Date
3.9 Global Anti-TNF-α Monoclonal Antibody Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Abbive
4.1.1 Abbive Company Information
4.1.2 Abbive Business Overview
4.1.3 Abbive Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Abbive Anti-TNF-α Monoclonal Antibody Product Portfolio
4.1.5 Abbive Recent Developments
4.2 Johnson and Johnson
4.2.1 Johnson and Johnson Company Information
4.2.2 Johnson and Johnson Business Overview
4.2.3 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product Portfolio
4.2.5 Johnson and Johnson Recent Developments
4.3 UCB
4.3.1 UCB Company Information
4.3.2 UCB Business Overview
4.3.3 UCB Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
4.3.4 UCB Anti-TNF-α Monoclonal Antibody Product Portfolio
4.3.5 UCB Recent Developments
5 Global Anti-TNF-α Monoclonal Antibody Market Scenario by Region
5.1 Global Anti-TNF-α Monoclonal Antibody Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Anti-TNF-α Monoclonal Antibody Sales by Region: 2021-2032
5.2.1 Global Anti-TNF-α Monoclonal Antibody Sales by Region: 2021-2026
5.2.2 Global Anti-TNF-α Monoclonal Antibody Sales by Region: 2027-2032
5.3 Global Anti-TNF-α Monoclonal Antibody Revenue by Region: 2021-2032
5.3.1 Global Anti-TNF-α Monoclonal Antibody Revenue by Region: 2021-2026
5.3.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Region: 2027-2032
5.4 North America Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
5.4.1 North America Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2032)
5.4.3 North America Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
5.5.1 Europe Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2032)
5.5.3 Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
5.6.1 Asia Pacific Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2032)
5.6.3 Asia Pacific Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
5.7.1 South America Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2032)
5.7.3 South America Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.7.7 Colombia
5.8 Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
5.8.1 Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2032)
5.8.3 Middle East and Africa Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2032)
6.1.1 Global Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2032) & (Kg)
6.1.2 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2021-2032)
6.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Type (2021-2032)
6.2.1 Global Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2021-2032)
6.3 Global Anti-TNF-α Monoclonal Antibody Price by Type (2021-2032)
7 Segment by Application
7.1 Global Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2032)
7.1.1 Global Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2032) & (Kg)
7.1.2 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2021-2032)
7.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Application (2021-2032)
7.2.1 Global Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2021-2032)
7.3 Global Anti-TNF-α Monoclonal Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Anti-TNF-α Monoclonal Antibody Value Chain Analysis
8.1.1 Anti-TNF-α Monoclonal Antibody Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Anti-TNF-α Monoclonal Antibody Production Mode & Process
8.2 Anti-TNF-α Monoclonal Antibody Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Anti-TNF-α Monoclonal Antibody Distributors
8.2.3 Anti-TNF-α Monoclonal Antibody Customers
9 Global Anti-TNF-α Monoclonal Antibody Analyzing Market Dynamics
9.1 Anti-TNF-α Monoclonal Antibody Industry Trends
9.2 Anti-TNF-α Monoclonal Antibody Industry Drivers
9.3 Anti-TNF-α Monoclonal Antibody Industry Opportunities and Challenges
9.4 Anti-TNF-α Monoclonal Antibody Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Anti-TNF-α Monoclonal Antibody Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Anti-TNF-α Monoclonal Antibody Sales (Kg) of Manufacturers (2021-2026)
Table 7. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Anti-TNF-α Monoclonal Antibody Revenue of Manufacturers (2021-2026)
Table 9. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Anti-TNF-α Monoclonal Antibody Average Price (US$/Kg) of Manufacturers (2021-2026)
Table 11. Global Anti-TNF-α Monoclonal Antibody Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Anti-TNF-α Monoclonal Antibody, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Anti-TNF-α Monoclonal Antibody, Product Type & Application
Table 14. Global Anti-TNF-α Monoclonal Antibody Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Anti-TNF-α Monoclonal Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Abbive Company Information
Table 19. Abbive Business Overview
Table 20. Abbive Anti-TNF-α Monoclonal Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 21. Abbive Anti-TNF-α Monoclonal Antibody Product Portfolio
Table 22. Abbive Recent Developments
Table 23. Johnson and Johnson Company Information
Table 24. Johnson and Johnson Business Overview
Table 25. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 26. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product Portfolio
Table 27. Johnson and Johnson Recent Developments
Table 28. UCB Company Information
Table 29. UCB Business Overview
Table 30. UCB Anti-TNF-α Monoclonal Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 31. UCB Anti-TNF-α Monoclonal Antibody Product Portfolio
Table 32. UCB Recent Developments
Table 33. Global Anti-TNF-α Monoclonal Antibody Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 34. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2021-2026) & (Kg)
Table 35. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2021-2026)
Table 36. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2027-2032) & (Kg)
Table 37. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2027-2032)
Table 38. Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2021-2026) & (US$ Million)
Table 39. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2021-2026)
Table 40. Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2027-2032) & (US$ Million)
Table 41. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2027-2032)
Table 42. North America Anti-TNF-α Monoclonal Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. North America Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg)
Table 44. North America Anti-TNF-α Monoclonal Antibody Sales by Country (2027-2032) & (Kg)
Table 45. North America Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2026) & (US$ Million)
Table 46. North America Anti-TNF-α Monoclonal Antibody Revenue by Country (2027-2032) & (US$ Million)
Table 47. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 48. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg)
Table 49. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2027-2032) & (Kg)
Table 50. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2026) & (US$ Million)
Table 51. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2027-2032) & (US$ Million)
Table 52. Asia Pacific Anti-TNF-α Monoclonal Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 53. Asia Pacific Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg)
Table 54. Asia Pacific Anti-TNF-α Monoclonal Antibody Sales by Country (2027-2032) & (Kg)
Table 55. Asia Pacific Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2026) & (US$ Million)
Table 56. Asia Pacific Anti-TNF-α Monoclonal Antibody Revenue by Country (2027-2032) & (US$ Million)
Table 57. South America Anti-TNF-α Monoclonal Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 58. South America Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg)
Table 59. South America Anti-TNF-α Monoclonal Antibody Sales by Country (2027-2032) & (Kg)
Table 60. South America Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2026) & (US$ Million)
Table 61. South America Anti-TNF-α Monoclonal Antibody Revenue by Country (2027-2032) & (US$ Million)
Table 62. Middle East and Africa Anti-TNF-α Monoclonal Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 63. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg)
Table 64. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2027-2032) & (Kg)
Table 65. Middle East and Africa Anti-TNF-α Monoclonal Antibody Revenue by Country (2021-2026) & (US$ Million)
Table 66. Middle East and Africa Anti-TNF-α Monoclonal Antibody Revenue by Country (2027-2032) & (US$ Million)
Table 67. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (Kg)
Table 68. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2027-2032) & (Kg)
Table 69. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2021-2026)
Table 70. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2027-2032)
Table 71. Global Anti-TNF-α Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million)
Table 72. Global Anti-TNF-α Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million)
Table 73. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2021-2026)
Table 74. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2027-2032)
Table 75. Global Anti-TNF-α Monoclonal Antibody Price by Type (2021-2026) & (US$/Kg)
Table 76. Global Anti-TNF-α Monoclonal Antibody Price by Type (2027-2032) & (US$/Kg)
Table 77. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (Kg)
Table 78. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2027-2032) & (Kg)
Table 79. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2021-2026)
Table 80. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2027-2032)
Table 81. Global Anti-TNF-α Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million)
Table 82. Global Anti-TNF-α Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million)
Table 83. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2021-2026)
Table 84. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2027-2032)
Table 85. Global Anti-TNF-α Monoclonal Antibody Price by Application (2021-2026) & (US$/Kg)
Table 86. Global Anti-TNF-α Monoclonal Antibody Price by Application (2027-2032) & (US$/Kg)
Table 87. Key Raw Materials
Table 88. Raw Materials Key Suppliers
Table 89. Anti-TNF-α Monoclonal Antibody Distributors List
Table 90. Anti-TNF-α Monoclonal Antibody Customers List
Table 91. Anti-TNF-α Monoclonal Antibody Industry Trends
Table 92. Anti-TNF-α Monoclonal Antibody Industry Drivers
Table 93. Anti-TNF-α Monoclonal Antibody Industry Restraints
Table 94. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Anti-TNF-α Monoclonal Antibody Product Image
Figure 5. Global Anti-TNF-α Monoclonal Antibody Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Anti-TNF-α Monoclonal Antibody Market Size (2021-2032) & (US$ Million)
Figure 7. Global Anti-TNF-α Monoclonal Antibody Sales (2021-2032) & (Kg)
Figure 8. Global Anti-TNF-α Monoclonal Antibody Average Price (US$/Kg) & (2021-2032)
Figure 9. Infliximab Product Image
Figure 10. Pecerizumab Product Image
Figure 11. Golimumab Product Image
Figure 12. Adalimumab Product Image
Figure 13. Rheumatoid Arthritis Product Image
Figure 14. Ankylosing Spondylitis Product Image
Figure 15. Psoriasis Product Image
Figure 16. Other Product Image
Figure 17. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Manufacturers in 2025
Figure 18. Global Manufacturers of Anti-TNF-α Monoclonal Antibody, Manufacturing Sites & Headquarters
Figure 19. Global Top 5 and 10 Anti-TNF-α Monoclonal Antibody Players Market Share by Revenue in 2025
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. Global Anti-TNF-α Monoclonal Antibody Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 22. Global Anti-TNF-α Monoclonal Antibody Sales by Region in 2025
Figure 23. Global Anti-TNF-α Monoclonal Antibody Revenue by Region in 2025
Figure 24. North America Anti-TNF-α Monoclonal Antibody Market Size by Country in 2025
Figure 25. North America Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2032)
Figure 26. North America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2021-2032)
Figure 27. United States Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Canada Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Anti-TNF-α Monoclonal Antibody Market Size by Country in 2025
Figure 30. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2032)
Figure 31. Europe Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2021-2032)
Figure 32. Germany Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Netherlands Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Asia Pacific Anti-TNF-α Monoclonal Antibody Market Size by Country in 2025
Figure 38. Asia Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2032)
Figure 39. Asia Pacific Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2021-2032)
Figure 40. China Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Japan Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. South Korea Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. India Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Australia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. China Taiwan Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Southeast Asia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Southeast Asia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. South America Anti-TNF-α Monoclonal Antibody Market Size by Country in 2025
Figure 49. South America Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2032)
Figure 50. South America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2021-2032)
Figure 51. Mexico Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Brazil Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Argentina Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Colombia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size by Country in 2025
Figure 56. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2032)
Figure 57. Middle East and Africa Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2021-2032)
Figure 58. Turkey Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Saudi Arabia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. UAE Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2021-2032)
Figure 62. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2021-2032)
Figure 63. Global Anti-TNF-α Monoclonal Antibody Price (US$/Kg) by Type (2021-2032)
Figure 64. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2021-2032)
Figure 65. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2021-2032)
Figure 66. Global Anti-TNF-α Monoclonal Antibody Price (US$/Kg) by Application (2021-2032)
Figure 67. Anti-TNF-α Monoclonal Antibody Value Chain
Figure 68. Anti-TNF-α Monoclonal Antibody Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Anti-TNF-α Monoclonal Antibody Industry Opportunities and Challenges
提及公司
AbbiveJohnson and JohnsonUCB
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們